The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Its' drop was approximate to its' dividend. This can be frequent behaviour.
good time to buy
Bought more today, attractive fundamentals and good growth story emerging.
Very good rise....i think it willnpast 1200p.....maybe 1300p
It's a waiting game this share business one need a lot of patience. I hope you hit your target soon. Gl
That could explain the 15% rise in 2 days. Been waiting patiently for over a year now...
It's to do with a possible deal Al noor merging with a South African company. Am not in here but have been watching from the sidelines. Good luck
Any news why the share has moved so much over the past 2 days ?
Looks like the rebound after the unexpexcted and frankly non-sensical fall...£11 awaits
Big drop today I know they go ex div tomorrow's!
great results. sp down....
Great rise the last couple of weeks!
Results are out soon should be good news.
But yes Shabzay also right I think.
More likely I think because of oil price fall and concern that that might affect middle eastern spending on healthcare among other things. But overdone I'd say - health isn't something people tend to budget on. NMC healthcare also worth a look - similar sort of share.
Thnks shabzay, I like the ROCE and announcements coming up
PE of pver 26 and DY of less than 1%...I think it is overpriced...Just my opinion, but good long term stable prospects. Company is cash rich, but a bit boring !! I sold out a few months ago at approx £10
Guys any idea why this has been falling over the last few months?
Agree, this could grow rapdily !!
Healthy !
UAE crashing - may fall further, avoid. If it reaches support at 800. I will buy
Hi All, Not seen too much activity on this biard for this share for a while. What are peoples thought on it right now for an investment at around 1035?
...has treated me well.
Anyone know why the share price is so low? The results seemed excellent. I was treated in Al Noor when I was living in Abu Dhabi and it was a great hospital.
Al Noor Hospitals Group's announcement that is has bought the Gulf International Cancer Centre is another important strategic step, according to Jefferies International. The largest private healthcare service provider in Abu Dhabi bought the centre, which offers a range of treatments in oncology, for $21.8m as part of a strategy to broaden its range of services. Jefferies, which recommended a 'buy' rating for the stock, said the company continues to execute in-line with what it communicates.